Compare BLCO & OCTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | OCTV |
|---|---|---|
| Founded | 1853 | 2017 |
| Country | Canada | United States |
| Employees | 13000 | N/A |
| Industry | Ophthalmic Goods | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 5.1B |
| IPO Year | 2022 | 2025 |
| Metric | BLCO | OCTV |
|---|---|---|
| Price | $16.94 | $19.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $19.04 | ★ $22.93 |
| AVG Volume (30 Days) | 288.1K | ★ 2.2M |
| Earning Date | 10-28-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $7.71 | $0.67 |
| Revenue Next Year | $5.86 | $4.94 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.77 | $15.41 |
| 52 Week High | $18.92 | $20.58 |
| Indicator | BLCO | OCTV |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 52.50 |
| Support Level | $16.94 | $16.85 |
| Resistance Level | $17.21 | $20.14 |
| Average True Range (ATR) | 0.39 | 0.68 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 45.28 | 51.95 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Octave Intelligence PLC provides a suite of software solutions that help organizations design, build, operate, and protect their physical assets, people, and critical infrastructure. The company operates in a single business segment developing enterprise software used in design, construction, operations, and security. Geographically, it operates in Americas that includes the United States, and Other Americas (Canada, and Latin America); EMIA that includes Europe, Middle East, India, and Africa; and APAC that includes the Asia-Pacific region, excluding India. The company derives maximum revenue from Americas. Its products include: Octave Coda Spatial, Octave Alto Twin, Octave Coda, Octave Oncall, Octave Alto, Octave Imagine, Octave Oncall Dispatch, Octave Alto Lightspeed, and Others.